Aspirin can exacerbate liver damage in cirrhosis by increasing bleeding risk. Use should be strictly monitored, potentially at reduced doses or avoided.

Patients with cirrhosis taking aspirin are at higher risk of gastrointestinal bleeding. It’s essential to assess bleeding risks vs. benefits and adjust dosage accordingly.

In cirrhosis, aspirin may lead to worsened liver function and increased bleeding. Monitoring with regular liver function tests and possibly reducing the dose is recommended.